Mometazonă Atb (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometazonă Atb, is a corticosteroid presented as a topical formulation for skin use. It is employed to reduce inflammation and relieve symptoms of various dermatological conditions in patients requiring localized therapy.

GNH USA supplies Mometazonă Atb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a topical corticosteroid used to manage inflammatory skin disorders.

- Atopic dermatitis: reduces redness, swelling and itching associated with eczema. - Psoriasis: decreases plaque formation and erythema on affected skin. - Seborrheic dermatitis: controls scaling and erythema on scalp and facial areas.

Topical application of mometasone furoate may be associated with a range of adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Skin irritation or mild erythema. - Dryness or peeling of the treated area. - Pruritus (itching) unrelated to the underlying condition. - Folliculitis or acneiform eruptions. - Telangiectasia (visible small blood vessels).

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Hypopigmentation or depigmentation of the skin. - Allergic contact dermatitis. - Secondary bacterial, fungal or viral skin infections. - Systemic adrenal suppression when large areas are treated. - Delayed wound healing or ulceration.

When using topical mometasone furoate, certain precautions should be observed.

- Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a physician, as drug may be excreted in milk. - Broken or infected skin: avoid application unless directed by a clinician. - Prolonged or extensive use: limit duration and surface area to reduce risk of skin atrophy. - Concomitant topical steroids: monitor for additive corticosteroid effects. - Store at room temperature: keep in the original container, protect from moisture and light.

Mometasone furoate may interact with other medications, altering its safety profile.

Major Interactions (Avoid):\n- Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure. - Antifungal agents applied to the same area: potential additive irritation.

Moderate Interactions (Monitor Closely): - Photosensitizing drugs (e.g., tetracyclines): heightened risk of sunburn. - Retinoids (topical or oral): may increase skin irritation. - Immunosuppressants: monitor for signs of infection due to combined immunosuppressive action.